mounjaro glp 1 gip Mounjaro: How It Works, How to Take It, and Side Effects Protein Intake for GLP-1 Users

The SELECT cardiovascular outcomes trial (NEJM, 2023) showed a 20% reduction in major adverse cardiovascular events among patients with existing heart disease -- data that no other GLP-1 in this class has yet matched

The survey is open to all and may be of interest to patients, healthcare professionals, and manufacturers

Metabolic disease including insulin resistance and fatty liver is closely related and often studied in the same models

Create a structured side effect log that records the specific symptom, severity (mild/moderate/severe), timing relative to medication dose, duration, and any interventions attempted